Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Join us and our co-hosts for this free virtual event on 28-29th April 2021 to hear the latest developments from international leaders in these fields


 

Cancer Research UK Oxford Centre, alongside Ludwig Cancer Research and the Oxford Centre for Early Cancer Detection, are co-hosting the Ludwig-Oxford Symposium on Cancer Early Detection and Epigenetics on 28 – 29 April 2021.

Registration is now open for an exciting programme of talks on the latest developments in cancer early detection and cancer epigenetics research.

Open to all – and suitable for scientists in basic, translational or clinical research – this free virtual event will bring together international leaders in these fields to discuss key advances and stimulate ideas.

Topics will include Early Detection TechnologiesRisk Stratification for Early Cancer DetectionChromatin and Cancerand Nucleic Acid Modifications and CancerSessions will run from approximately 15:00-19:00 (London)/10:00-14:00 (New York) each day.

Confirmed speakers include:

  • Naomi Allen (University of Oxford)
  • Eleanor Barnes (University of Oxford)
  • Stephen B. Baylin (Ludwig Cancer Research, Johns Hopkins School of Medicine)
  • Shelley Berger (University of Pennsylvania)
  • Sangeeta Bhatia (Ludwig Cancer Research, Massachusetts Institute of Technology)
  • Chuan He (Ludwig Cancer Research, University of Chicago)
  • Nada Jabado (McGill University)
  • Cigall Kadoch (Ludwig Cancer Research, Dana Farber Cancer Institute)
  • Kenneth W. Kinzler (Ludwig Cancer Research, Johns Hopkins School of Medicine)
  • Tony Kouzarides (University of Cambridge)
  • Nickolas Papadopoulos (Ludwig Cancer Research, Johns Hopkins School of Medicine)
  • Gillian Reeves (University of Oxford)
  • Jens Rittscher (Ludwig Cancer Research, University of Oxford)
  • Yang Shi (Ludwig Cancer Research, University of Oxford)
  • Chunxiao Song (Ludwig Cancer Research, University of Oxford)

Please register for the event here.

Enquiries should be directed to conference@ludwig.ox.ac.uk

 

Similar Stories

Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS

A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.

Oxford Cancer Analytics awarded £1.27M to revolutonise lung cancer management

OXcan, an Oxford University spin out, has raised money to apply their machine learning approach to lung cancer early detection

Oxford’s cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection

Research from Dr Brian Nicholson and colleagues outlines how routine clinical tests could be widely used to estimate the risk of cancer for people visiting their GPs with unexpected weight loss.